mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.1 |
mRNA |
MK-2206 |
GDSC1000 |
pan-cancer |
AAC |
-0.052 |
0.2 |
mRNA |
Axitinib |
FIMM |
pan-cancer |
AAC |
0.22 |
0.2 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.2 |
mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.072 |
0.2 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
-0.06 |
0.2 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
BRD-K75293299 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.2 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |